Phase I Study of Tivozanib Eye Drops in Healthy Volunteers and Patients with Neovascular Age-Related Macular Degeneration по Fumi Gomi, MD, PhD, Tomohiro Iida, MD, PhD, Ryusaburo Mori, MD, PhD, Shinya Horita, PhD, MBA, Hiroaki Nakamura, MS, Yu Nakajima, MMath, Ayako Shiokawa, BPharm, Kanji Takahashi, MD, PhD

Полный текст